Bath & Body Works Cuts 2025 Outlook as Candle and Fragrance Sales Falter

Bath & Body Works (NYSE: BBWI) shocked markets on Thursday by slashing its annual profit and revenue projections. The company cited weaker-than-expected sales for candles and fragrances as shoppers tighten their belts and production costs climb.

Originally forecasting a modest sales increase between 1.5% and 2.7% for 2025, Bath & Body Works now anticipates a decline in net sales by low single digits. This reversal signals a concerning hit to one of its core product lines, which has long been a consumer favorite and a key revenue driver.

The earnings per share estimate was also sharply cut to at least $2.87 from an earlier range of $3.35 to $3.60. Such a reduction hints at squeezed margins as the company navigates the storm of supply chain pressures and cautious consumer behavior in a budget-conscious environment.

Shares of BBWI took an immediate hit, tumbling roughly 15% in premarket trading as investors absorbed the downgrade. The steep drop underlines market sensitivity to shifting consumer trends in discretionary spending, particularly in lifestyle and home fragrance categories.

Bath & Body Works' situation highlights a broader challenge for specialty retailers facing a consumer base that is balancing spending with inflationary pressures. Candles and fragrances, often seen as non-essential treats, are taking a backseat as shoppers prioritize essentials.

The revised forecast raises questions about how sustainable Bath & Body Works' growth trajectory is in the current economic cycle. Profitability depends heavily on reviving demand or offsetting slower sales with cost efficiencies, but rising expenses make the latter a tough nut to crack.

Interestingly, the company hasn't indicated any dramatic shifts in strategy or product innovation yet, leaving the market to wonder if Bath & Body Works will pivot aggressively to regain momentum or stick to its playbook.

With holiday shopping season underway, this forecast cut might add pressure to the stock heading into peak sales months. Whether Bath & Body Works can weather this rough patch or if the softness signals a deeper consumer retreat from such categories remains to be seen.